OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE. (May 2022)

Record Type:: Journal Article
Title:: OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE. (May 2022)
Main Title:: OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE
Authors:: Macaluso, F.S.
Grova, M.
Saladino, M.
Demarzo, M.G.
Privitera, A.C.
Giangreco, E.
Garufi, S.
Renna, S.
Casà, A.
Ventimiglia, M.
Cappello, M.
Fries, W.
Orlando, A.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 54(2022)Supplement 2
Journal:: Digestive and liver disease
Issue:: Volume 54(2022)Supplement 2
Issue Display:: Volume 54, Issue 2 (2022)
Year:: 2022
Volume:: 54
Issue:: 2
Issue Sort Value:: 2022-0054-0002-0000
Page Start:: S93
Page End:: S94
Publication Date:: 2022-05
Subjects:: Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S1590-8658(22)00328-0 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21460.xml